This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Herborium Group Completes Manufacturing Of Its Sexual Health Formulas; Ready To Take Advantage Of $1.5 Billion Market.

FORT LEE, N.J., Feb. 14, 2013 /PRNewswire/ -- Herborium Group, Inc., (OTC Pink: HBRM) www.herborium.com, a Botanical Therapeutics® Company has  announced today that it has completed the manufacturing of  its unique, all herbal Sexual Enhancement Products Lasting Pleasure® for women and Lasting Power® for men. After the products are packaged using a very attractive and unique, environmentally sustainable European package design they are both expected to hit the market in March 2013.

Lasting Pleasure® and Lasting Power® represent over $1.5 billion market potential  for natural sexual health products and has already been featured in November 2012, USA Today, Sexual Health Issue: "Healthy Relationships."

In addition, there is a growing need for women's sexual health products. The female sexual enhancement industry is poised for an explosion and is expected to grow into a multibillion dollar business as women themselves become increasingly aware of their sexuality and their sexual health. In 2012 the sales of female personal lubricants grew 41%. There is no Viagra comparative product on the market for women and Herborium's Lasting Pleasure® for Women is the ONLY product of its kind.

"We are extremely excited to be preparing an immediate roll-out of our sexual health products and we cannot find a better day to announce it - than a Valentine's Day."  Commented Dr. Agnes P. Olszewski, Chairwoman & CEO of Herborium. "Herborium's sexual enhancement products' trajectory is for long term growth and it is also supported by its association with Kamasutra™ Spirit of Seduction – an innovative adult beverage developed with an unique herbal formula invented by Herborium.  Kamasutra™  social  media presence,  www.kamasutraspirit.com and each bottle of Kamasutra™ product include references to Herborium's sexual health products. This represents a measurable value and most advantageous marketing opportunities for Lasting Pleasure® and Lasting Power®," concluded Dr. Olszewski.

About Herborium Group, Inc.

Herborium Group, Inc., a B otanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals.  The Company uses clinical validation to establish and maintain a differential advantage.  The company sells its products in the US and Europe. For more information, please visit www.herborium.com, www.herboriumsh.com, and www.acnease.com.

One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire: Investorsrelations@herborium.com

SOURCE Herborium Group, Inc.

Stock quotes in this article: HBRM 
Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs